...
首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Anti-nociceptive effect of stigmasterol in mouse models of acute and chronic pain
【24h】

Anti-nociceptive effect of stigmasterol in mouse models of acute and chronic pain

机译:急性和慢性疼痛小鼠模型中Stigmasterol的抗伤害作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Stigmasterol is a common sterol found in plants, but the anti-nociceptive effect of this compound and its mechanism of action are not fully explored. Thus, in the present study, the anti-nociceptive effect of stigmasterol was investigated in acute and chronic models of pain and its mechanism of action. We used adult male albino Swiss mice (25-35 g) to observe the anti-nociceptive effect of stigmasterol in acetic-acid writhing test or in complete Freund's adjuvant injection, surgical incision in hind paw, or partial sciatic nerve ligation. Moreover, we investigate the involvement of opioid receptors (naloxone, 2 mg/kg, intraperitoneally) in stigmasterol anti-nociceptive effect and stigmasterol action on acetylcholinesterase activity. Some possible adverse effects caused by stigmasterol were also investigated. Stigmasterol (0.3-3 mg/kg, orally) exhibited an anti-nociceptive effect on acetic-acid-induced writhing test. Furthermore, it markedly attenuated the mechanical allodynia caused by surgical incision (after acute treatment with stigmasterol, preventive and curative effects were observed) and partial sciatic nerve ligation (after acute treatment with stigmasterol) and complete Freund's adjuvant (after acute or repeated treatment with stigmasterol). The anti-nociceptive effect of stigmasterol was not reversed by naloxone. Moreover, stigmasterol did not alter in vitro acetylcholinesterase activity in spinal cord or brain samples. Also, stigmasterol did not cause gastric ulcers or alter the gastrointestinal transit of mice. Taken together, these results support the potential anti-nociceptive effect of stigmasterol in different models of pain.
机译:Stigmasterol是一种常见的甾醇,在植物中发现,但该化合物的抗伤害效果及其作用机制未得到充分探索。因此,在本研究中,在急性和慢性模型的疼痛和其作用机制中研究了Stigmasterol的抗伤害作用。我们使用成人雄性白化瑞士小鼠(25-35g)观察醋酸扭曲试验或完全弗氏佐剂注射,后爪手术切口或部分坐骨神经连接的抗伤害效果。此外,我们研究了阿片受体(Naloxone,2mg / kg,腹膜内)在乙酰胆碱酯酶活性上的抗摩托醇抗伤害作用和柱司醇作用的累积。还研究了由Stigmasterol引起的一些可能的不良反应。 Stigmasterol(0.3-3mg / kg,口服)对醋酸诱导的扭曲试验表现出抗伤害效果。此外,它显着衰减了由外科切口引起的机械异常疼痛(在急性治疗后,观察到预防和治疗效果)和部分坐骨神经结扎(急性治疗后急性治疗)和完全弗氏佐剂(急性或急性或用Stigmasterol重复治疗后) )。纳洛酮的抗伤害效果尚未逆转。此外,Stigmasterol在脊髓或脑样品中没有改变体外乙酰胆碱酯酶活性。此外,Stigmasterol没有引起胃溃疡或改变小鼠的胃肠道过境。连同,这些结果支持不同疼痛模型中斯蒂姆斯特罗的潜在抗伤害效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号